NASDAQ:AKTX
Akari Therapeutics Plc Stock Earnings Reports
$1.21
+0.105 (+9.55%)
At Close: Apr 17, 2025
Akari Therapeutics Plc Earnings Calls
Q1 2025
Release date | Apr 16, 2025 |
EPS estimate | - |
EPS actual | - |
Revenue estimate | - |
Revenue actual | - |
Q4 2024
Release date | Mar 28, 2025 |
EPS estimate | - |
EPS actual | - |
Revenue estimate | - |
Revenue actual | - |
Q3 2024
Beat
-$0.0001 (99.98%)
Release date | Nov 19, 2024 |
EPS estimate | -$0.600 |
EPS actual | -$0.0001 |
EPS Surprise | 99.98% |
Revenue estimate | - |
Revenue actual | - |
Q2 2024
Beat
-$0.0004 (99.96%)
Release date | Aug 19, 2024 |
EPS estimate | -$1.00 |
EPS actual | -$0.0004 |
EPS Surprise | 99.96% |
Revenue estimate | - |
Revenue actual | - |
Last 4 Quarters for Akari Therapeutics Plc
Below you can see how AKTX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q2 2024
Beat
Release date | Aug 19, 2024 |
Fiscal end date | Jun 30, 2024 |
Price on release | $3.60 |
EPS estimate | -$1.00 |
EPS actual | -$0.0004 |
EPS surprise | 99.96% |
Date | Price |
---|---|
Aug 13, 2024 | $3.46 |
Aug 14, 2024 | $3.34 |
Aug 15, 2024 | $3.19 |
Aug 16, 2024 | $3.42 |
Aug 19, 2024 | $3.60 |
Aug 20, 2024 | $3.59 |
Aug 21, 2024 | $3.59 |
Aug 22, 2024 | $3.71 |
Aug 23, 2024 | $3.84 |
4 days before | 4.05% |
4 days after | 6.67% |
On release day | -0.278% |
Change in period | 10.98% |
Q3 2024
Beat
Release date | Nov 19, 2024 |
Fiscal end date | Sep 30, 2024 |
Price on release | $1.57 |
EPS estimate | -$0.600 |
EPS actual | -$0.0001 |
EPS surprise | 99.98% |
Date | Price |
---|---|
Nov 13, 2024 | $2.24 |
Nov 14, 2024 | $2.23 |
Nov 15, 2024 | $2.08 |
Nov 18, 2024 | $2.29 |
Nov 19, 2024 | $1.57 |
Nov 20, 2024 | $1.47 |
Nov 21, 2024 | $1.24 |
Nov 22, 2024 | $1.30 |
Nov 25, 2024 | $1.03 |
4 days before | -29.91% |
4 days after | -34.39% |
On release day | -6.37% |
Change in period | -54.02% |
Q4 2024
Release date | Mar 28, 2025 |
Fiscal end date | Dec 30, 2024 |
Price on release | $1.27 |
EPS estimate | - |
EPS actual | - |
Date | Price |
---|---|
Mar 24, 2025 | $1.45 |
Mar 25, 2025 | $1.46 |
Mar 26, 2025 | $1.31 |
Mar 27, 2025 | $1.30 |
Mar 28, 2025 | $1.27 |
Mar 31, 2025 | $1.24 |
Apr 01, 2025 | $1.10 |
Apr 02, 2025 | $1.10 |
Apr 03, 2025 | $1.19 |
4 days before | -12.41% |
4 days after | -6.30% |
On release day | -2.36% |
Change in period | -17.93% |
Q1 2025
Release date | Apr 16, 2025 |
Fiscal end date | Mar 30, 2025 |
Price on release | $1.10 |
EPS estimate | - |
EPS actual | - |
Date | Price |
---|---|
Apr 10, 2025 | $1.11 |
Apr 11, 2025 | $1.07 |
Apr 14, 2025 | $1.11 |
Apr 15, 2025 | $1.20 |
Apr 16, 2025 | $1.10 |
Apr 17, 2025 | $1.21 |
4 days before | -0.90% |
4 days after | 9.55% |
On release day | 9.55% |
Change in period | 8.56% |
Akari Therapeutics Plc Earnings History
Earnings Calendar
FAQ
What is the AKTX price-to-earnings (P/E) ratio?
AKTX P/E ratio as of Apr 17, 2025 (TTM) is -0.687.
What are Akari Therapeutics Plc's retained earnings?
On its balance sheet, Akari Therapeutics Plc reported retained earnings of $0 for the latest quarter ending Mar 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.